Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma

Identifying Potential Gene Defect Patterns Related to COVID-19 Based on Pharmacological and Bioinformatics Analysis for Lung Adenocarcinoma

Hongqiang Lou, Xusheng Li, Suhua Gao, Yanfang Zhang, Haohao Chen, Xia Zhai Medical Molecular Biology Laboratory, School of Medicine, Jinhua Polytechnic, Jinhua City, Zhejiang Province, 330700, People’s Republic of ChinaCorrespondence: Xia Zhai, Medical Molecular Biology Laboratory, School of Medicin...

Full description

Bibliographic Details
Main Authors:	Lou H, Li X, Gao S, Zhang Y, Chen H, Zhai X
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-04-01
Series:	International Journal of General Medicine
Subjects:	covid-19 lung adenocarcinoma traditional chinese medicine drug targets tumor microenvironment molecular subtypes
Online Access:	https://www.dovepress.com/identifying-potential-gene-defect-patterns-related-to-covid-19-based-o-peer-reviewed-fulltext-article-IJGM

Similar Items

Novel immune subtypes of lung adenocarcinoma identified through bioinformatic analysis
by: Fang‐lu Qin, et al.
Published: (2020-09-01)

Macrophage-related molecular subtypes in lung adenocarcinoma identify novel tumor microenvironment with prognostic and therapeutic implications
by: Heng Wen, et al.
Published: (2022-10-01)

Identification and Validation of the Pyroptosis-Related Molecular Subtypes of Lung Adenocarcinoma by Bioinformatics and Machine Learning
by: Le-Ping Liu, et al.
Published: (2021-11-01)

Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma
by: Jingchen Zhang, et al.
Published: (2022-06-01)

Molecular map of disulfidptosis-related genes in lung adenocarcinoma: the perspective toward immune microenvironment and prognosis
by: Fangchao Zhao, et al.
Published: (2024-02-01)

Characterization of molecular subtypes based on chromatin regulators and identification of the role of NPAS2 in lung adenocarcinoma
by: Yongbiao Huang, et al.
Published: (2023-04-01)

m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma
by: Guangyao Wang, et al.
Published: (2022-08-01)

Comprehensive Profiling Reveals Distinct Microenvironment and Metabolism Characterization of Lung Adenocarcinoma
by: Chang Li, et al.
Published: (2021-05-01)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
by: Yang Song, et al.
Published: (2020-07-01)

Novel Genetic Prognostic Signature for Lung Adenocarcinoma Identified by Differences in Gene Expression Profiles of Low- and High-Grade Histological Subtypes
by: Chia-Ching Chang, et al.
Published: (2022-01-01)

Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma
by: Hao Sun, et al.
Published: (2020-10-01)

Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma
by: Hyun Woo Jeon, et al.
Published: (2021-07-01)

Wnt signaling pathway-derived score for predicting therapeutic resistance and tumor microenvironment in lung adenocarcinoma
by: Hao-min Zhou, et al.
Published: (2023-01-01)

Classification of lung adenocarcinoma based on stemness scores in bulk and single cell transcriptomes
by: Qian Liu, et al.
Published: (2022-01-01)

Evaluating distinct KRAS subtypes as potential biomarkers for immune checkpoint inhibitor efficacy in lung adenocarcinoma
by: Qi Wang, et al.
Published: (2023-10-01)

Identification of lung adenocarcinoma subtypes and a prognostic signature based on activity changes of the hallmark and immunologic gene sets
by: Shun-Kai Zhou, et al.
Published: (2024-04-01)

Deep learning for predicting subtype classification and survival of lung adenocarcinoma on computed tomography
by: Chengdi Wang, et al.
Published: (2021-08-01)

Prognostic Nomograms Based on Ground Glass Opacity and Subtype of Lung Adenocarcinoma for Patients with Pathological Stage IA Lung Adenocarcinoma
by: Wenyu Zhai, et al.
Published: (2021-12-01)

Simplified molecular classification of lung adenocarcinomas based on EGFR, KRAS, and TP53 mutations
by: Roberto Ruiz-Cordero, et al.
Published: (2020-01-01)

Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity
by: Xiao Li, et al.
Published: (2024-03-01)

Characterization of polyamine metabolism predicts prognosis, immune profile, and therapeutic efficacy in lung adenocarcinoma patients
by: Zhouhua Li, et al.
Published: (2024-04-01)

Identification of four metabolic subtypes and key prognostic markers in lung adenocarcinoma based on glycolytic and glutaminolytic pathways
by: Jinjin Zhang, et al.
Published: (2023-02-01)

Platelet Count is Associated with the Rate of Lymph Node Metastasis in Lung Adenocarcinoma
by: Qu C, et al.
Published: (2020-10-01)

Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma
by: Yanju Lv, et al.
Published: (2022-10-01)

Analysis of clinicopathology and CT features of histology subtypes of invasive lung adenocarcinoma
by: HE Xiaoqun, et al.
Published: (2020-10-01)

Identification of a novel prognostic signature related to PANoptosis and its regulatory mechanism as well as targeted treatment of active ingredients and traditional Chinese medicine in lung adenocarcinoma
by: Shaohui Wang, et al.
Published: (2022-03-01)

Prognosis of resected invasive mucinous adenocarcinoma compared with the IASLC histologic grading system for invasive nonmucinous adenocarcinoma: Surgical database study in the TKIs era in Korea
by: Wongi Woo, et al.
Published: (2022-12-01)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
by: Zhike Chen, et al.
Published: (2023-04-01)

NF1 mutations identify molecular and clinical subtypes of lung adenocarcinomas
by: Camille Tlemsani, et al.
Published: (2019-08-01)

Comprehensive Analysis to Identify Enhancer-Regulated Inflammation-Associated Genes in Lung Adenocarcinoma
by: Li X, et al.
Published: (2021-09-01)

Solid histological component of adenocarcinoma might play an important role in PD‐L1 expression of lung adenocarcinoma
by: Tomoyuki Miyazawa, et al.
Published: (2022-01-01)

Genomic landscape of lung adenocarcinomas in different races
by: Huashan Shi, et al.
Published: (2022-09-01)

Characterization of Tumor Microenvironment in Lung Adenocarcinoma Identifies Immune Signatures to Predict Clinical Outcomes and Therapeutic Responses
by: Donglai Chen, et al.
Published: (2021-03-01)

Necroptosis Identifies Novel Molecular Phenotypes and Influences Tumor Immune Microenvironment of Lung Adenocarcinoma
by: Chen Zhao, et al.
Published: (2022-07-01)

Vasculogenic mimicry score identifies the prognosis and immune landscape of lung adenocarcinoma
by: Weichang Yang, et al.
Published: (2023-06-01)

Histological and prognostic data on surgically resected early-stage lung adenocarcinoma
by: Masaya Yotsukura, MD, et al.
Published: (2020-08-01)

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
by: Yuan Cui, et al.
Published: (2022-09-01)

Bioinformatics analysis of microarray data to identify the candidate biomarkers of lung adenocarcinoma
by: Tingting Guo, et al.
Published: (2019-07-01)

Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis
by: Yang FR, et al.
Published: (2022-07-01)

The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics
by: Kewei Ni, et al.
Published: (2019-08-01)